(NASDAQ: ENSC) Ensysce Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,307.59%.
Ensysce Biosciences's earnings in 2026 is -$12,623,900.On average, 3 Wall Street analysts forecast ENSC's earnings for 2026 to be -$2,163,206,357, with the lowest ENSC earnings forecast at -$2,078,374,735, and the highest ENSC earnings forecast at -$2,226,830,073.
In 2027, ENSC is forecast to generate -$992,296 in earnings, with the lowest earnings forecast at -$953,383 and the highest earnings forecast at -$1,021,482.